Alvaro Torres, President & CEO of Khiron Life Sciences Corp. Khiron is listed on the TSX.V under the symbol KHRN. Khiron is a medical cannabis company incorporated in Canada, with corporations in Colombia.
We are looking at the untapped, domestic market. In Colombia with 50 million people, Latin America with 640 million that have tremendous need for these types of products. We are ready to come out with products at the end of this year then we’ll have eager patients and eager doctors to begin prescription and consumption of the high quality products that we’ll produce.
In the end, anytime somebody’s talking about medical cannabis in Latin America, the only brand that they’re going to care about is going to be Khiron.” – Alvaro Torres, President & CEO of Khiron Life Sciences Corp.
Khiron is a Canadian integrated medical cannabis company with its core operations in Colombia, and is fully licenced in Colombia for the cultivation, production, domestic distribution, and international export of both tetrahydrocannabinol (THC) and cannabidiol (CBD) medical cannabis. Khiron combines leading international scientific expertise, agricultural advantages, and branded product market entrance experience to address the unmet medical needs in a market of over 620 million people in Latin America.
For more information on Khiron Life Sciences Corp. (KHRN:TSX.V)